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Background: Sweat chloride test is the gold standard test for cystic ﬁbrosis (CF) diagnosis. Sweat conductivity is widely used although still
considered a screening test.
Methods: This was a prospective, cross-sectional, diagnostic research conducted at the laboratory of the Instituto da Criança of the Hospital das
Clínicas, São Paulo, Brazil. Sweat chloride (quantitative pilocarpine iontophoresis) and sweat conductivity tests were simultaneously performed in
patients referred for a sweat test between March 2007 and October 2008. Conductivity and chloride cut-off values used to rule out or diagnose CF
were b75 and ≥90 mmol/L and b60 and ≥60 mmol/L, respectively. The ROC curve method was used to calculate the sensitivity, speciﬁcity,
positive (PPV) and negative predictive value (NPV), as well as the respective 95% conﬁdence intervals and to calculate the area under the curve for
both tests. The kappa coefﬁcient was used to evaluate agreement between the tests.
Results: Both tests were performed in 738 children, and CF was ruled out in 714 subjects; the median sweat chloride and conductivity values were
11 and 25 mmol/L in these populations, respectively. Twenty-four patients who had received a diagnosis of CF presented median sweat chloride
and conductivity values of 87 and 103 mmol/L, respectively. Conductivity values above 90 mmol/L had 83.3% sensitivity, 99.7% speciﬁcity,
90.9% PPV and 99.4% NPV to diagnose CF. The best conductivity cut-off value to exclude CF was b75 mmol/L. Good agreement was observed
between the tests (kappa: 0.934).
Conclusions: The sweat conductivity test yielded a high degree of diagnostic accuracy and it showed good agreement with sweat chloride. We
suggest that it should play a role as a diagnostic test for CF in the near future.
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The sweat test remains the gold standard test for diagnosis of
cystic fibrosis (CF) despite the identification of over 1900
mutations in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene [1]. CF is confirmed when sweat chloride
values are ≥60 mmol/L, when two CF-causing mutations are
detected or when there is increased nasal potential difference
associated with the clinical phenotypic features of the disease
[2–5]. The diagnosis criteria for CF have been revised, and new
reference values for sweat chloride have been established for
infants younger than 6 months: normal values are lower thanby Elsevier B.V. All rights reserved.
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[5–7].
In 1959, Gibson and Cooke developed the measurement of
sweat chloride concentration by the quantitative pilocarpine
iontophoresis test (QPIT) method and tested 25 CF patients and
64 controls [8]. The CF patients' sweat chloride values were
≥80 mEq/L and none of the controls had sweat chloride values
greater than 60 mEq/L. Since then, the measurement of sweat
chloride by the QPIT has been considered the gold standard
method to diagnose CF. However, this test is cumbersome to
perform and requires the weighing of the sweat sample, elution
of sweat from the filter paper or gauze used to collect it and
chemical analysis of electrolytes after dilution of the sweat
sample [9]. The procedure is vulnerable to errors if not
performed by experienced professionals who are specifically
trained in sweat collection and analysis. In the past years it has
become common in many CF centers to use the macroduct®
coils for sweat collection keeping the quantitative analysis of
chloride, which makes QPIT easier [10].
The conductivity sweat test is a simpler sweat test method
that eliminates the weighing and dilution steps and also reduces
the risk of sample evaporation. Studies comparing the QPIT to
the conductivity test have been conducted since late 1950 and
have shown good correlation and agreement between chloride
and conductivity values [11–21]. It should be emphasized that
the reference values for sweat conductivity are different from
those for sweat chloride because of the presence of unmeasured
anions such as lactate and bicarbonate when sweat conductivity
is analyzed, although the test does reflect the concentration of
sodium chloride as the primary sweat component. As a result,
sweat conductivity values are approximately 15 mmol/L higher
than sweat chloride values. Values higher than 90 mmol/L support
a CF diagnosis [20], although the manufacturer of sweat conduc-
tivity equipment recommends values higher than 80 mmol/L as
diagnostic [22].
CF is frequently under-diagnosed and/or diagnosed late in
Brazil, partly because of the complexity of the sweat test and
the scarcity of professionals trained to properly conduct the
QPIT.
The objective of the present study was to compare sweat
chloride values obtained by the QPIT with sweat conductivity
values collected using the macroduct® system in a sample of
patients being investigated for CF and to assess the accuracy of
the conductivity test as a diagnostic procedure.
2. Methods
This study was a prospective, cross-sectional, diagnostic
research conducted at the laboratory of the Instituto da Criança
of the Hospital das Clínicas, São Paulo, Brazil, from March
2007 to October 2008. This is a referral laboratory for the sweat
test that follows the British guidelines [23]. All patients referred
to the laboratory in the study period for a sweat test because of
a suspicion of CF were invited to participate. An inclusion
criterion was a sufficient sweat sample with both techniques.
Exclusion criteria were patients doing a repeat sweat test to
avoid bias in the sensitivity and specificity results and patientson oral steroid therapy. This study was approved by the Human
Ethics Committee of the Hospital das Clínicas of the Medical
School of the University of São Paulo (approval number 609/04).
Written informed consent was obtained from all subjects or their
parents.
Both types of sample were collected at the same time from
each of the patients' forearms as described below:3. Sweat collection
3.1. Classic sweat test: QPIT collected onto filter paper
(Gibson & Cooke technique)
The skin of the forearm was cleaned by using distilled water
and dried with gauze. Copper electrodes 2.5 × 2.5 cm were then
placed on the skin using strapped-on gauze embedded in 0.5%
pilocarpine nitrate solution (positive electrode) and sulfuric acid
0.004 N (negative electrode). A current of 2 to 5 mA was applied
for 5 min. After iontophoresis was completed, the electrodes were
removed and the skin was cleaned again with distilled water and
dried with gauze. Then, a disk of filter paper of 4.2 cm (Whatman
filter paper number 42) was removed from a previously weighed
bottle, placed over the area that was iontophoresed and covered
with a plastic square and adhesive tape. After 30 min, the moist
filter paper was removed, returned to the bottle and reweighed by
using an analytical scale to measure the mass of the sweat. The
minimum accepted sample weight was 75 mg. The paper was
then placed inside a glass container, which was sealed with plastic
to be sent to the laboratory for chloride analysis (coulometric
titration using a digital chloridometer – Labconco®). The sweat
was eluted from the filter paper with 10 ml of distilled water.3.2. Sweat conductivity test: macroduct® sweat collection
system with analysis of electrolytes based on conductivity
The skin of the forearm was cleaned by using 70% alcohol
followed by distilled water and wiped clean using gauze. This
cleaning step was followed by sweat stimulation using electrodes
with pilocarpine gel disks (Pilogel®) applied over the skin and
the passage of an electric current of 1.5 mA for 5 min. After
iontophoresis, the area was cleanedwith distilled water and wiped,
and the macroduct® collector was then tightened by using straps.
Sweat collection lasted for 30 min and a minimum amount of
15 μl was required. After the collection process, the catheter was
separated from the disk and a syringe was connected to one end of
the catheter. The other end was connected to the Sweat-Chek®
analyzer device, which measured the conductivity of the sample
and converted the measured values into sodium chloride molarity
unit equivalents. The value of conductivity was that when the
reading was stabilized for approximately 10 s. The Sweat-Chek®
analyzer measurements were regularly verified by using standard
Wescor® NaCl standard sweat controls (with approximately
40, 70 and 130 mmol/L). When the reading given by the analyser
did not agree with the specified molarity of the standard
solution recalibration was performed with a calibrator solution
(90 mmol/L) according to the manufacturer recommendations.
Table 1
Characteristics of the patients.
Non-CF patients
(n = 714)
CF patients
(n = 24)
Age (years), mean ± SD 4.2 ± 4.2 3.6 ± 4.1
Median (range) 2.5 (0.1 a 19.2) 2.4 (0.1 to 13)
Male sex, n (%) 399 (56%) 15 (62.5%)
Ethnicity, n (%)
Caucasians 569 (79.7%) 21 (87.5%)
African descent 136 (19%) 3 (12.5%)
Asian descent 9 (1.3%) –
Referral diagnosis, n (%)
Wheezing baby 200 (28.1%) 1 (4%)
Asthma 170 (24%) 2 (8.5%)
Upper and/or lower respiratory symptoms
and/or digestive symptoms
122 (17%) –
Recurrent pneumonia 116 (16.2%) –
Failure to thrive 47 (6.5%) –
Family history of CF 20 (2.8%) 3 (12.5%)
Chronic diarrhea 16 (2.2%) –
Bronchiectasis 12 (1.7%) –
Chronic cough 11 (1.5%) 2 (8.5%)
Positive newborn screening – 6 (25%)
Rectal prolapse – 1 (4%)
Not available – 9 (37.5%)
Table 2
Sweat chloride and sweat conductivity in non-CF and CF patients.
Non-CF patients (n = 714) CF patients (n = 24)
Sweat tests (mmol/L) Chloride Conductivity Chloride Conductivity
Median 11 25 87 103
Mean ± SD 13.4 ± 8.7 28.3 ± 12 90.3 ± 20 99.7 ± 18
Range 3–137 14–138 54–132 50–126
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followed by bursts of air to purge any remaining droplets,
between the tests. Conductivity was measured at 23 °C and the
principal investigator performed all the tests. The technician
who performed the chloride measurements was not aware of the
conductivity test results.
A CF diagnosis was established when the chloride concentra-
tion was ≥60 mmol/L in two sweat samples associated with a
clinical CF phenotype. A CF diagnosis was also established when
borderline sweat chloride values were associated with a clinical
CF phenotype or when borderline values were accompanied by
two disease-causing CFTR gene mutations. CF was ruled out
when the chloride concentration was less than 40 mmol/L (less
than 30 mmol/L in infants up to 6 months old) and the child did
not fulfill the clinical criteria for a CF diagnosis.
4. Statistical analysis
Conductivity cut-off values to rule out or diagnose CFwere set
at b75 and ≥90 mmol/L, respectively, and the chloride cut-off
values were b60 and ≥60 mmol/L. These cut-off values of
conductivity were selected based on the largest study by Lezana
et al. comparing both sweat test techniques [20]. Borderline
values for conductivity were defined as 75 to 89 mmol/L and
those for sweat chloride were defined as 40 to 59 mmol/L.
Receiver operator characteristic (ROC) curves were construct-
ed (MedCalc® program version 11.2.0.0) to calculate the
sensitivity, specificity, positive (PPV) and negative predictive
values (NPV) and respective 95% confidence intervals (95CI%)
of the conductivity test and also to calculate the area under the
curve for the two tests in order to assess their accuracy. Kappa
coefficient was calculated to evaluate the agreement between the
two tests.
This was a diagnostic research questioning if the test in study
would distinguish patients with and without CF among patients in
whom it was clinically reasonable to suspect of CF [24]. As we
hypothesized that we would have only around 10 diagnosis of CF
in the study period, we planned to perform around 700 tests in
order to achieve good sensitivity, specificity, PPV and NPV for
the conductivity test and not to have an unstable confidence
interval.
5. Results
Both types of sweat test were simultaneously performed on the
forearms of 738 patients. CF was ruled out in 714 (96.7%) patients,
whereas CF was diagnosed in 24 patients (3.3%). The clinical
characteristics of the 714 patients without CF are described in
Table 1.
Median sweat chloride and conductivity values of 11 and
25 mmol/L, respectively, were observed in these 714 patients
without CF (Table 2). Sweat conductivity values were equal to or
greater than 90 mmol/L in three patients without a clinical CF
phenotype and they represent the false-positive tests (Table 3).
Of the 714 patients without CF, excluding the three false-
positive results mentioned above, conductivity values were
equal to or higher than 50 mmol/L in only 37 patients (5.2%),and only three had values between 75 and 89. Only 43 infants
without CF were less than 6 months old (excluding the patient
with pseudohypoaldosteronism), and a sweat conductivity higher
than 50 mmol/L (54 mmol/L) was observed in only one case
with a normal concomitant sweat chloride value.
The clinical characteristics of the 24 patients with CF are
shown in Table 1. Median sweat chloride and conductivity values
of 87 and 103 mmol/L, respectively, were observed in these
patients, of whom 11 were less than 6 months of age (Table 2).
Three patients had sweat conductivity values less than 90 mmol/L
and they represent the false-negative tests (Table 3).
A comparison was made between males and females (CF and
non-CF) in both sweat conductivity and chloride and no
differences were found (Table 4).
The sensitivity, specificity, PPV and NPV for a CF diagnosis
when sweat conductivity values were≥90 mmol/L are shown in
Table 5. With sweat conductivity values less than 75 mmol/L, a
CF diagnosis could very likely be ruled out (99.7%NPV; 95%CI:
99.0–100%). A very large area under the curve was found in
the ROC curve analysis, which demonstrates that the values
determined by using the conductivitymethod closely matched the
chloride test values (Fig. 1). Excellent agreement was found
Table 3
False positive and false negative sweat conductivity test.
Sweat tests (mmol/L) Chloride Conductivity
Dyshidrosis 55 98
Pseudohypoaldosteronism 137 138
Chronic sinusitis 47 90
Atypical CF— case #1 54 57
Atypical CF— case #2 56 50
CF 83 85
Table 5
Sensitivity and specificity of the sweat conductivity and sweat chloride tests.
CF patients Non-CF patients
Conductivity Chloride Conductivity Chloride
Positive test 21 22 3 1
Negative test 3 2 711 713
Total 24 24 714 714
95%CI = 95% confidence interval; PPV = positive predictive value; NPV =
negative predictive value. ROC curve for conductivity: sensitivity = 83.3%
(95%CI: 62.6–95.2); specificity = 99.7% (95%CI: 99.0–100); PPV = 90.9%
(95%CI: 70.8–98.6); NPV = 99.4% (95%CI: 98.6–99.8). Borderline values for
both conductivity and chloride were taken as negative.
531A.C.V. Mattar et al. / Journal of Cystic Fibrosis 13 (2014) 528–533between the sweat chloride and conductivity methods, with a
kappa value of 0.934 (95% CI: 0.86–1.009).
6. Discussion
The main result of our study was to show that the conductivity
sweat test is an accurate, highly sensitive and specific method
with a high capacity to discriminate between CF and non-CF
subjects. Good agreement was observed between the sweat
chloride and conductivity methods.
The conductivity method was applied in 738 subjects with
clinically suspected CF: CF was ruled out in 714 patients and
diagnosed in 24. In the 714 non-CF patients, only three tests had
false-positive results: conductivity values of 138, 98 and 90 mmol/L
and chloride values of 137, 55 and 47 mmol/L, respectively. In
these cases, the diagnoses were pseudohypoaldosteronism, which
is a condition associated with false-positive sweat chloride results,
dyshidrosis and chronic sinusitis. The patient with chronic sinusitis
might represent a mild CF spectrum disease. As two additional
sweat chloride tests for this patient were in the normal range, chest
computed tomography (CT) and spirometry were normal, as well
as the nutritional status, CF was ruled out.
Three conductivity tests were false-negative: two patients had a
diagnosis of atypical CF based on borderline sweat chloride values
and clinical features of CF. One was a patient with pancreatic
insufficiency, bronchiectasis, Pseudomonas aeruginosa in the
sputum and severe airway obstruction on spirometry. His sweat
chloride was 56 and conductivity of 50 mmol/L. Two other sweat
chloride tests had values of 41 and 28 mmol/L. Only the
p.F508del and the p.G542X mutations were analyzed and were
not found. He is in regular follow up at this CF clinic and is
receiving specific treatment for CF. The other patient had an initial
diagnosis of wheezing baby, had no pancreatic insufficiency or
specific lung pathogens and one p.G542X mutation was found.
Her sweat chloride was 54 and conductivity of 57 mmol/L. A
second measured sweat chloride value was 53 mmol/L. She is
being treated with inhaled steroids for asthma, but CF was notTable 4
Sweat chloride and sweat conductivity among CF and non-CF female and male sub
Non-CF patients
Sweat tests (mmol/L) Chloride Conductivity
Gender Female Male Female M
Median 10 12 26 25
Mean ± SD 13.4 ± 10 13.3 ± 7 29.5 ± 14 27
Range 3–137 3–51 14–138 15
Number of subjects: non-CF female = 315; CF female = 9; non-CF male = 399; CFruled out. The third case (sweat chloride of 83 and conductivity of
85 mmol/L) was a CF patient with no respiratory symptoms thus
far, with pancreatic sufficiency and with one p.F508del mutation.
An extended CFTR mutation analysis has not yet been performed
in these three patients. These three cases reinforce the notion that
the diagnosis of CF in any patient will require clinical evaluation, a
sweat test and genetic testing and that patients with borderline
sweat tests (either chloride or conductivity) always pose a
diagnostic challenge, besides raising the issue of the appropriate
cut-off values for diagnostic categories for both techniques.
Several studies have already demonstrated an excellent
agreement between sweat chloride and conductivity, and their
results are summarized in Table 6. All of these studies have
concluded that the sweat conductivity method is as effective as
the chloride test in the laboratory diagnosis of CF with a similar
ability to distinguish patients with or without CF. The main
criticism of conductivity is that it does not measure chloride
ions alone but sodium chloride, besides lactate and bicarbonate
and this might impair a CF diagnosis. Physicians should pay
attention on the reference values for sweat conductivity, that are
different from sweat chloride, when analyzing a sweat test
result.
Nanoduct® is a new diagnostic system that induces, collects
and analyzes sweat conductivity in one step. Two studies in
large populations, including infants with positive newborn
screening for CF, also demonstrated this method to be a good
diagnostic test compared to sweat chloride to diagnose or rule
out CF [25,26].
A cut-off point of 90 mmol/L for a CF diagnosis was chosen
based on the largest study comparing both sweat test techniques.
Lezana et al. [20] studied 3834 patients and found a high
correlation between the methods with regard to their ability to
confirm and to rule out CF. In 3540 patients without CF, the
authors found a median conductivity of 36 mmol/L, and in 294jects.
CF patients
Chloride Conductivity
ale Female Male Female Male
87 87 96 104
.3 ± 9 89.5 ± 22 90.8 ± 20 97.1 ± 18 101.2 ± 18
–75 54–132 56–129 57–117 50–126
male = 15
Fig. 1. The ROC (receiver operating characteristics) curve obtained for 738
subjects to assess the capacity of conductivity (NaCl = sodium chloride) to
predict a cystic fibrosis diagnosis. Solid line: area under the curve for
conductivity (99.4%). Dashed line: 95% confidence interval (98.6–99.8%).
532 A.C.V. Mattar et al. / Journal of Cystic Fibrosis 13 (2014) 528–533patients with CF the median conductivity was 111 mmol/L.
These authors found that the conductivity cut-off value for
optimal prediction of a positive CF diagnosis was ≥90 mmol/L,
which was associated with a greater than 99% sensitivity,
specificity, PPV and NPV. Similarly, the conductivity cut-off
value for optimal prediction of a negative CF diagnosis was
b75 mmol/L, with 93% NPV. When we used the same cut-off
values as Lezana et al., we observed that with a conductivity
value higher than 90 mmol/L, we had greater than 80%
sensitivity, specificity, PPV and NPV for a CF diagnosis. Most
importantly, with a sweat conductivity value lower than
75 mmol/L, CF could very likely be ruled out (NPV 99.7%). A
very large area under the curve in the ROC analysis was found,
which demonstrates that the conductivity method closely
matched the sweat chloride method. When we set the cut-off
point for conductivity at 80 mmol/L for a CF diagnosis, anTable 6
Studies comparing sweat conductivity with sweat chloride in CF and non-CF patien
Study Number of
CF patients
CF patients Numbe
non-CF
Mean conductivity
(mmol/L)
Mean chloride
(mmol/L)
Hammond et al. [16]. 43 113.1 98.8 471
Mastella et al. [17]. 103 112 95.7 184
Heeley et al. [18]. 57 110 99 154
Riedi et al. [19]. 31 118.5 113.2
(sodium)
175
Lezana et al. [20]. 294 111
(median)
Not mentioned 3540
Mattar et al. [21]. 52 119.7 110.5 50
R = correlation coefficient; ROC = receiver operator characteristic; CI = confidence
⁎ Equivocal results: conductivity— 1:57 CF, 2:154 non-CF; chloride— 1:57 CFincrease in sensitivity (92%) occurred concomitantly with a
decrease in the PPV (85%), whereas the test retained good
specificity and NPV (above 99%).
If we followed the CF Foundation recommendation, that is,
to perform a QPIT in all patients that present with a sweat
conductivity value ≥50 mmol/L, a QPIT should have been
performed in only 37 non-CF patients based on conductivity
values between 50 and 89 mmol/L. This strategy would save
our sweat test laboratory from performing 674 QPITs.
Although there is a lower incidence of CF in Brazil (estimates
of 1 in 7576 live births) compared to European and North
American countries [27] CF newborn screening is increasingly
being implemented in our country using the IRT/IRT (immuno-
reactive trypsinogen) algorithm, and so the demand for sweat
testing has tremendously increased because of numerous
false-positive results generated by this algorithm. In Brazil, the
QPIT is mainly performed in laboratories of university hospitals
linked to a CF center, such as ours. With this increased demand
for sweat testing, conductivity could be evaluated as the first
sweat test in these infants and also in other patients referred for a
sweat test because of a clinical suspicion of CF. When values are
between 50 and 79 mmol/L, QPIT and chloride analysis should
be performed in an accredited CF center. When two sweat
conductivity tests return values higher than 80 mmol/L and there
are clinical features of the disease, a CF diagnosis can be
established. This strategy would prevent under-diagnosis and
also prevent delayed CF diagnoses.
Although the QPIT is still traditionally used to confirm a
diagnosis of CF, sweat conductivity should be considered an
alternative test for a CF diagnosis [28,29], as it has already been
compared to sweat chloride in over 6000 patients and has
demonstrated good agreement with sweat chloride testing.
Staff responsible for sweat conductivity evaluation should gain
sufficient experience and familiarity with the test and maintain
their expertise by performing this technique regularly. Accuracy in
sweat collection with quantity verification, instrument calibration,
cell cleaning and drying, avoiding cell infiltration by air bubbles
and other delicate steps requires experienced and responsible staff
to ensure the accuracy of the conductivity result [30]. Setting the
positive cut-off value at 80 mmol/L, as recommended by thets.
r of
patients
Non-CF patients Statistics
Mean conductivity
(mmol/L)
Mean chloride
(mmol/L)
33.4 16.4 r = 0.974
39.8 16.3 r = 0.988
37 14 Not mentioned ⁎
40.9 36.3
(sodium)
r = 0.99
36
(median)
Not mentioned Kappa coefficient = 0.998
34.4 17.4 Area under the ROC curve:
100% (95CI%: 96.4–100%)
interval;
, 1:154 non-CF.
533A.C.V. Mattar et al. / Journal of Cystic Fibrosis 13 (2014) 528–533manufacturer, may be safer than setting the cut-off at 90 mmol/L
to not miss a CF diagnosis, and we suggest that values between 50
and 79 mmol/L should be considered borderline and that these
patients should undergo a QPIT for a chloride analysis.
In conclusion, sweat conductivity showed an excellent capacity
to discriminate between CF and non-CF subjects with a high
degree of diagnostic accuracy, and it showed good agreement with
sweat chloride. It is our view that sweat conductivity should play a
role as a diagnostic test for CF in the near future.
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